Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01083147 · ClinicalTrials.gov registry record
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
A clinical trial, sponsored by Notal Vision.
- Completed
- Registry status
- 50
- Enrollment target
NCT01083147: Completed study, sponsored by Notal Vision.
NCT01083147 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01083147 has completed, sponsored by Notal Vision.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
Interventions
- DEVICE FORESEE HOME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-09 |
What the finished NCT01083147 record still lists
NCT01083147 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FORESEE HOME is the first listed.
NCT01083147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01083147 about?
NCT01083147 is a clinical study titled "Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment". The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
What is the current status of trial NCT01083147?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01083147?
The interventions under investigation include: FORESEE HOME (DEVICE).
Who is sponsoring clinical trial NCT01083147?
This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia